Rutgers University Study of the Genetics of Breast Cancer.
Rutgers, The State University of New Jersey · with Regeneron Pharmaceuticals · NCT06773897
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 25000
- US sites recruiting
- 1
- Study start
- April 15, 2024
- Record last updated
- October 16, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this observational study is to learn more about how genes impact the risk of breast cancer. Anyone 18 or older living in the US is eligible, and a diagnosis of cancer is NOT required. Study participation is online, and it takes about 20 minutes to complete health surveys and request a saliva collection kit sent through US mail. In return, study participants may opt to receive information about their genetic ancestry at no cost.
Being studied: Saliva sample; Health Surveys
Conditions: Breast Cancer Risk; Breast Cancer Prevention; Breast Cancer
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- age 18 years or older
- currently living in the United States
- able to understand and follow written instructions in English
- have access to the internet and a computer, laptop, tablet or smart phone
- willing to provide written informed consent for participation
- willing to provide DNA via a saliva sample using a collection kit mailed to the study participant's home
- willing to complete a survey with questions about health related to the study of breast cancer.
Exclusion Criteria
- Not able to meet or fulfill any of the inclusion criteria
Recruiting US locations
Rutgers University
Piscataway, NJ 08854
Site contact: Tara Matise, Ph.D. · 848-445-3125 · rugcc@rutgers.edu
Study contacts (from the official record)
- Tara Matise, Ph.D. · 848-445-3125 · rugcc@rutgers.edu
- Steve Buyske, Ph.D. · 848-445-7680 · rugcc@rutgers.edu
Similar studies in New Jersey
All healthy volunteers studies in New Jersey →- RecruitingHealthy volunteersPhase 1
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Arcutis Biotherapeutics, Inc.
- Location
- Fair Lawn, NJ + 6 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Clinical Trial of MK-1406 in Healthy Participants (MK-1406-008)
Merck Sharp & Dohme LLC
- Location
- Marlton, NJ + 5 other US sites
- Eligibility basics
- Ages 18–64
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Jersey City, NJ + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
Study of Single Doses of HBS-104 in Acutely Sleep-deprived Healthy Participants
Harmony Biosciences Management, Inc.
- Location
- Eatontown, NJ
- Eligibility basics
- Ages 18–55